Effects of Luteolin on Spatial Memory, Cell Proliferation, and Neuroblast Differentiation in the Hippocampal Dentate Gyrus in a Scopolamine-induced Amnesia Model
Overview
Authors
Affiliations
Objectives: Luteolin, a common flavonoid from many plants, has various pharmacological activities, including a memory-improving effect. In this study, we investigated the effects of luteolin on spatial memory, cell proliferation, and neuroblast differentiation in the hippocampal dentate gyrus in a rat model of scopolamine (SCO)-induced amnesia.
Methods: Scopolamine was subcutaneously administered for 28 days via an Alzet minipump (44 mg/ml delivered at 2·5 μl/h) along with a daily intraperitoneal administration of vehicle (saline) 10 mg/kg luteolin or 5 mg/kg galantamine (GAL) (a control drug for acetylcholinesterase (AChE) inhibitor) for 28 days.
Results: The administration of SCO significantly decreased the spatial alteration percentage in the Y-maze test compared to that in the vehicle (saline)-treated group. The administration of luteolin or GAL significantly improved the spatial alteration percentage compared to that in the SCO-treated group. Similarly, the administration of SCO significantly decreased the cell proliferation (Ki67-positive cells) and neuroblast differentiation (doubleocortin-positive cells) in the dentate gyrus. The administration of luteolin or GAL significantly mitigated the SCO-induced reduction of Ki67- and doublecortin-immunoreactive cells in the dentate gyrus. In addition, the administration of luteolin significantly decreased the lipid peroxidation (malondialdehyde (MDA) levels) and increased the brain-derived neurotrophic factor (BDNF) and AChE levels in the hippocampal homogenates compared to the SCO-treated group.
Conclusion: These results suggest that the luteolin treatment improves the SCO-induced reduction of cell proliferation and neuroblast differentiation in the dentate gyrus. The mechanism underlying the amelioration of SCO-induced amnesia by luteolin may be associated with the increase in BDNF, acetylcholine, and the decrease in lipid peroxidation.
Abbas H, Sayed N, Abou Youssef N, Gaafar P, Mousa M, Fayez A Pharmaceutics. 2022; 14(5).
PMID: 35631589 PMC: 9148113. DOI: 10.3390/pharmaceutics14051003.
Elsheikh M, El-Feky Y, Al-Sawahli M, Ali M, Fayez A, Abbas H Pharmaceutics. 2022; 14(3).
PMID: 35335952 PMC: 8950550. DOI: 10.3390/pharmaceutics14030576.
Nguyen H, Le X, Van Nguyen T, Phung H, Nguyet Pham H, Nguyen K J Nat Med. 2022; 76(3):621-633.
PMID: 35218459 DOI: 10.1007/s11418-022-01609-2.
Co-Ultra PEALut Enhances Endogenous Repair Response Following Moderate Traumatic Brain Injury.
Campolo M, Crupi R, Cordaro M, Cardali S, Ardizzone A, Casili G Int J Mol Sci. 2021; 22(16).
PMID: 34445417 PMC: 8395716. DOI: 10.3390/ijms22168717.
Le X, Nguyen H, Van Nguyen T, Nguyet Pham H, Nguyen P, Nguyen K Evid Based Complement Alternat Med. 2021; 2021:6627648.
PMID: 34306149 PMC: 8266455. DOI: 10.1155/2021/6627648.